IMMP

Immutep Limited

4.30 USD

Last updated Oct 7, 19:11 UTC

Yesterday HIGH

$4.51

Yesterday LOW

$4.3

52w HIGH

$5.36

52w LOW

$0.26

EPS

-0.04

PE

-113.16

Next Earnings

Feb 24, 2027

Overview News Government Trades Fundamentals

Immutep Limited stock is up 1,094.44% since 30 days ago. The next earnings date is Feb 24, 2027. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 14 October’s closed higher than September.

Benzinga Newsdesk

Thu May 28, 2026

Immutep Announces Results From Systematic Evaluation Of 5 Clinical Trials Of Eftilagimod Alfa APC Activator In Combination With Standard-Of-Care Therapies In Late-Stage Cancer Patients
Benzinga Newsdesk

Thu Apr 30, 2026

Immutep Receives Nasdaq Noncompliance Notice, Gets Time Through Oct. 26 To Regain Compliance

Immutep Limited ((ASX: IMM, NASDAQ:IMMP) ("Immutep" or "the Company"), advises that it has received a written notification from The Nasdaq Stock Market LLC (Nasdaq) regarding non-compliance with the Nasdaq minimum bid
Avi Kapoor

Wed Apr 15, 2026

Nasdaq Surges 200 Points; Morgan Stanley Posts Upbeat Earnings

US stocks rise, Nasdaq up 200 points; Tech shares lead gains. Morgan Stanley beats estimates. Allbirds up 349%, Snap up 6%. Oil rises 0.7%, gold up 0.1%.
Benzinga Insights

Wed Apr 15, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session
Vandana Singh

Wed Apr 15, 2026

Immutep Gets FDA Boost For Lead Cancer Drug, Stock Doubles

Immutep stock jumps after FDA orphan drug tag for eftilagimod alfa, even as halted Phase 3 trial and mixed analyst views weigh on outlook.
Avi Kapoor

Wed Apr 15, 2026

Dow Gains 100 Points; Bank of America Earnings Top Views

US stocks up on Wed, Dow +0.22%, NASDAQ +0.37%, S&P 500 +0.28%. Bank of America beats Q1 earnings. Allbirds Inc. shares soar 323%.
Benzinga Newsdesk

Wed Apr 15, 2026

Immutep shares are trading higher after the FDA granted the company Orphan Drug Designation for for eftilagimod alfa for the treatment of Soft Tissue Sarcoma
Benzinga Insights

Wed Apr 15, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Newsdesk

Wed Apr 15, 2026

FDA Grants Immutep Orphan Drug Designation For Eftilagimod Alfa For Treatment Of Soft Tissue Sarcoma
Avi Kapoor

Wed Apr 15, 2026

Why NN Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

NN Inc. (NNBR) rose in pre-market trading after announcing expected sales growth and raising full-year guidance. Other gainers include NICM, AGAE, IMMP, LIMN, CIIT, MLSS, LAES, GBR, and STNE. Losers include SNAL, MIMI, ARAI, and SURG.

APLD $23.97 USD

ABBV $273.00 USD

DRAM DRAM $60.16 USD

CORZ $15.82 USD

SMCI $44.86 USD

CAT $810.97 USD

LUNR $14.38 USD